
    
      The proposed study is be a randomized, double-blind, placebo-controlled trial of
      supplementation with oral vitamin D3.

      Each subject will take a once-weekly capsule containing vitamin D3 or a an
      identical-appearing placebo for a treatment period of 15 weeks.

      Subjects will be assessed for Bone pain and tenderness, Neuromuscular function, physical
      performance score, and Quality of life assessment.

      A subset of subjects will have bone biopsies performed before and after intervention.
    
  